Sign in

CIK 0001953926 · <br>Emerging growth company

Zenas BioPharma, Inc.

Sign in to watch
Ticker
ZBIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
857-271-2954
Business address
852 WINTER STREET, SUITE 250, WALTHAM, MA, 02451
Former names
Zenas BioPharma (Cayman) Ltd
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2024-09-16 Fairmount Funds Management LLC Director Conversion · Series B Convertible Preferred Stock −6,163,236 0
2024-09-16 Fairmount Funds Management LLC Director Conversion · Series C Convertible Preferred Stock −2,614,287 0
2024-09-16 MOULDER LEON O JR Chief Executive Officer Conversion +164,523 1,280,022
2024-09-16 MOULDER LEON O JR Chief Executive Officer Conversion +108,381 112,901
2024-09-16 MOULDER LEON O JR Chief Executive Officer Conversion +372,017 1,652,039
2024-09-16 MOULDER LEON O JR Chief Executive Officer Conversion +48,254 161,155
2024-09-16 MOULDER LEON O JR Chief Executive Officer Conversion · Series Seed Convertible Preferred Stock −1,428,571 0
2024-09-16 MOULDER LEON O JR Chief Executive Officer Conversion · Series A Convertible Preferred Stock −941,088 0
2024-09-16 MOULDER LEON O JR Chief Executive Officer Conversion · Series B Convertible Preferred Stock −3,230,268 0
2024-09-16 MOULDER LEON O JR Chief Executive Officer Conversion · Series B Convertible Preferred Stock −418,996 0
2024-09-16 ENRIGHT PATRICK G Director Conversion +723,812 723,812
2024-09-16 ENRIGHT PATRICK G Director Conversion +1,003,592 1,727,404
2024-09-16 ENRIGHT PATRICK G Director Conversion +334,530 334,530
2024-09-16 ENRIGHT PATRICK G Director Purchase +440,000 $17.00 $7.5M 774,530
2024-09-16 ENRIGHT PATRICK G Director Conversion · Series B Convertible Preferred Stock −6,284,933 0
2024-09-16 ENRIGHT PATRICK G Director Conversion · Series C Convertible Preferred Stock −8,714,293 0
2024-09-16 ENRIGHT PATRICK G Director Conversion · Series C Convertible Preferred Stock −2,904,764 0
2024-09-16 Fairmount Funds Management LLC Director Conversion +41,130 41,140
2024-09-16 Fairmount Funds Management LLC Director Conversion +252,890 294,020
2024-09-16 Fairmount Funds Management LLC Director Conversion +709,794 1,003,814

Page 5 of 8 · 145 trades